Assessing the Bioavailability of Leading Phytonutrient Products

NCT ID: NCT05349032

Last Updated: 2022-04-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-01

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will primarily test various phytonutrient-based supplements to see which gets absorbed into the body the best. The study will secondarily look at inflammatory markers in the urine to determine any change.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will primarily test various phytonutrient-based supplements to see which gets absorbed into the body the best. 120 mg of curcumin from brands Meriva, CurcElite, Lonvida, UltraCur, NovaSol. The study will secondarily look at inflammatory markers in the urine to determine any change.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Meriva

120 mg of curcumin in Meriva.

Group Type OTHER

Curcumin

Intervention Type DIETARY_SUPPLEMENT

Oral supplement

Longvida

120 mg of curcumin Longvida.

Group Type OTHER

Curcumin

Intervention Type DIETARY_SUPPLEMENT

Oral supplement

NovaSol

120 mg of curcumin NovaSol

Group Type OTHER

Curcumin

Intervention Type DIETARY_SUPPLEMENT

Oral supplement

CurcElite

120 mg of curcumin CurcElite

Group Type OTHER

Curcumin

Intervention Type DIETARY_SUPPLEMENT

Oral supplement

UltaCur

120 mg of curcumin Ultracur

Group Type OTHER

Curcumin

Intervention Type DIETARY_SUPPLEMENT

Oral supplement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Curcumin

Oral supplement

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age and gender

Exclusion Criteria

* Cannot take any phytonutrient or curcumin supplement five days prior to commencement.
Minimum Eligible Age

21 Years

Maximum Eligible Age

49 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Epiceutical Labs

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

David Roberts

Charlottesville, Virginia, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

David Roberts, MPH

Role: CONTACT

810777687

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

David Roberts, MPH

Role: primary

434-981-8629

References

Explore related publications, articles, or registry entries linked to this study.

Jamwal R. Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers. J Integr Med. 2018 Nov;16(6):367-374. doi: 10.1016/j.joim.2018.07.001. Epub 2018 Jul 4.

Reference Type RESULT
PMID: 30006023 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

101

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.